- Potential benefitRaises public awareness and education about DES health effects and intergenerational risks.
- Potential benefitMay mobilize support to restore funding for the DES Follow-Up Study, enabling renewed research.
- Potential benefitCould lead to expanded healthcare screening, monitoring, and services for exposed individuals and descendants.
Recognizing the history of the drug diethylstilbestrol and the harm it has caused, and for other purposes.
Referred to the House Committee on Energy and Commerce.
This resolution is a House simple resolution expressing the House's views: supporting a DES Awareness Week, recognizing harms caused by diethylstilbestrol, urging restoration of study funding, and asking the FDA to apologize. It does not create legally binding requirements or change federal law. If adopted, it becomes the official statement of the House but does not force the FDA or other parties to act.
This non‑binding House resolution recognizes the history and harms of the drug diethylstilbestrol (DES), supports designating April 20–26, 2025, as DES Awareness Week, endorses restoring funding for the DES Follow‑Up Study, and urges the FDA to issue a formal apology to affected families.
As a House resolution it is declarative and does not create law; likely to be adopted in the House but not to become statute or compel action.
Relative to its intended legislative type, this bill functions primarily as a commemorative resolution that clearly states historical facts and expresses support for an awareness week, while also making hortatory requests (restore funding for a follow-up study; urge an FDA apology) without providing implementation detail, fiscal acknowledgement, or accountability mechanisms.
Progressives emphasize apology, research funding, and justice for victims
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Potential burdenThe resolution is symbolic and does not itself appropriate funds or change legal rights.
- Federal agenciesCalls to restore funding could increase federal expenditures if Congress enacts appropriations.
- Potential burdenAn apology without compensation may be criticized as insufficient by survivors seeking remedies.
Why the argument around this bill splits.
Progressives emphasize apology, research funding, and justice for victims
Strongly supportive.
Views the resolution as overdue recognition of state and federal responsibility, public health redress, and a step toward research and care for impacted families.
Generally supportive but cautious.
Likes recognition and research focus, while wanting clarity on costs, implementation, and avoiding unintended legal or budgetary consequences.
Skeptical.
Supports acknowledging victims and awareness week, but wary of implied new federal spending, agency apologies as precedent, and expanding federal responsibilities.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
As a House resolution it is declarative and does not create law; likely to be adopted in the House but not to become statute or compel action.
- Whether the House committee will schedule consideration
- Level of bipartisan cosponsorship and floor support
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Progressives emphasize apology, research funding, and justice for victims
As a House resolution it is declarative and does not create law; likely to be adopted in the House but not to become statute or compel acti…
Relative to its intended legislative type, this bill functions primarily as a commemorative resolution that clearly states historical facts and expresses support for an awareness week, while also making hortatory reques…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.